Zobrazeno 1 - 10
of 45
pro vyhledávání: '"E. Ösby"'
Publikováno v:
Europe PubMed Central
The monoclonal antibodies against CD8 (T suppressor/cytotoxic) antigen (Leu2/OKT8) were found to bind to leukaemic lymphocytes from a patient with chronic lymphocytic leukaemia. The cells also had an unusual type of rod-like cytoplasmic immunoglobuli
Publikováno v:
British Journal of Haematology. 51:531-539
Summary. Peripheral neuropathy has been described in malignant plasma cell dyscrasias such as multiple myeloma and Waldenstrom's macroglobulinaemia. Since it is not known whether the neuropathy is related to the plasma cell disorder or is a paramalig
Autor:
Hannu Pertovaara, Hans Hagberg, Harald Anderson, John Myhre, Björn Nilsson, E. Ösby, Harald Holte, Stein Kvaløy, Lasse Teerenhovi, Eva Cavallin-Ståhl, Magnus Björkholm, Åke Öst
Publikováno v:
Annals of Oncology. 18:1085-1089
Background: Secondary central nervous system (CNS) involvement by aggressive lymphoma is a well-known and dreadful clinical complication. The incidence and risk factors for CNS manifestation were studied in a large cohort of elderly (> 60 years) pati
Autor:
null The French Cooperative Group on CLL, S Johnson, A.G Smith, H Löffler, E Ösby, G Juliusson, B Emmerich, P.J Wyld, W Hiddemann
Publikováno v:
The Lancet. 347:1432-1438
Background: Fludarabine seems to be a promising treatment for patients with advanced chronic lymphocytic leukaemia (CLL). We compared fludarabine therapy with the combination of cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of CLL
Publikováno v:
European Journal of Haematology. 39:86-87
Autor:
Magnus Björkholm, A. Hedlund, P. Bernell, G. Grimfors, K. Merk, S. Widell, E. Ösby, Jan Liliemark, Fredrik Celsing, E. Svedmyr
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(11)
Summary Background Second- and third-generation chemotherapy protocols for the treatment of aggressive non-Hodgkin’s lymphomas (NHL) have considerable, and age-related, toxic effects. In addition, they do not seem to prolong overall survival in com
Autor:
L. Teerenhovi, S. Kvalöy, Hannu Pertovaara, John Myhre, H. Hagberg, E. Cavallin-Ståhl, E. Ösby, Harald Holte, H. Anderson, Å. Öst, Magnus Björkholm
Publikováno v:
Blood. 106:3333-3333
Introduction: Manifestation of central nervous system (CNS) disease in patients with aggressive non-Hodgkin’s lymphoma (NHL) during or after first line treatment is often a devastating condition, which is associated with a poor prognosis. There is
Publikováno v:
Journal of Neurology. 228:185-194
It is well known that peripheral neuropathy occurs in patients with myeloma or macroglobulinaemia, but its pathogenesis is still obscure. In recent years, neuropathy has also been reported in association with benign monoclonal or oligoclonal gammopat
Publikováno v:
Medical oncology and tumor pharmacotherapy. 4(2)
A case of idiopathic myelofibrosis with the unusual finding of osteolytic lesions is presented. Biopsies from the lesions showed proliferation of fibroblasts, megakaryocytes and myeloid cells.
Publikováno v:
Blut. 54(2)
Cyclosporine A (CyA) treatment of 4 patients with severe aplastic anemia, who were ineligible for bone marrow transplantation, was carried out for periods of between 12 weeks to 20 months. A normalization of Hb and bone marrow, together with a marked